Literature DB >> 29283942

Destructive Fibrosarcoma of the Maxillary Sinus.

Adnan Ekinci1, Duran Karataş1, Abdurrahman Yetiş1, Behice Hande Erenler2, Muge Ozcan1.   

Abstract

Paranasal fibrosarcoma of nasal cavity and paranasal sinuses is a very rare malignant tumor. It is usually presented with nasal obstruction and epistaxis. In this clinical report, clinical symptoms, pathogenesis, and treatment principles of a paranasal fibrosarcoma originating from the right maxillary sinus and obstructing the right nasal passage are discussed.A 55-year-old male patient was admitted to the authors clinic with complaints of nasal obstruction and epistaxis lasting for 2 years. Anterior rhinoscopy revealed a mass lesion which obstructed the right nasal passage and caused frequent epistaxis. An opacity consistent with soft tissue lesion which was originated from the right maxillary sinus and filled the right nasal passage was observed in paranasal tomography. Magnetic resonance imaging revealed that the mass lesion was contrasted. Tumor was seen to erode orbital floor, and lateral and anterior walls of the maxillary sinus. Biopsy result was reported as papilloma. The patient was treated with Denker approach as anterior wall of the maxillary sinus was eroded by the tumor lesion and the mass lesion was excised. The patient received postoperative radiotherapy as pathological diagnosis was reported as paranasal fibrosarcoma.

Entities:  

Mesh:

Year:  2018        PMID: 29283942     DOI: 10.1097/SCS.0000000000004173

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Reconstructive challenges of sinonasal tumors: A case report.

Authors:  Dragos Octavian Palade; Razvan Hainarosie; Mihaela Pertea; Florin Anghelina; Petronela Zaharia; Cătălina Pietroșanu; Valentin Calu; Valeriu Ardeleanu; Felicia Manole
Journal:  Exp Ther Med       Date:  2022-04-29       Impact factor: 2.447

Review 2.  Fibrosarcomas of the Paranasal Sinuses: A Systematic Review.

Authors:  Moneb S Bughrara; Tarek Almsaddi; Jithin John; Brandon Prentice; Jared Johnson; Oswaldo Henriquez; Adam J Folbe
Journal:  Cureus       Date:  2022-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.